ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Enveric Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.39+0.01 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $5.54M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
11.8%
1M of 4M shares
Institutional holders
24
14 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Steven Boyd | 405,092 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Lind Global Partners III LLC | 141,265 | 9.99% | 13G (passive) | Jan 28, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ENVB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sio Capital Management, LLC | 180,000 | 4.02% | $248.40K | New | 0.04% |
| Ikarian Capital, LLC | 100,002 | 2.23% | $138.00K | New | 0.01% |
| AdvisorShares Investments LLC | 35,417 | 0.79% | $48.88K | +18,443 | 0.01% |
| Renaissance Technologies LLC | 32,058 | 0.72% | $44.24K | New | 0.00% |
| Armistice Capital, LLC | 32,000 | 0.71% | $44.16K | New | 0.00% |
| Boothbay Fund Management, LLC | 30,142 | 0.67% | $41.60K | New | 0.00% |
| XTX Topco Ltd | 18,990 | 0.42% | $26.21K | New | 0.00% |
| Hrt Financial LP | 15,458 | 0.35% | $21 | New | 0.00% |
| Vanguard Capital Management LLC | 14,912 | 0.33% | $20.58K | New | 0.00% |
| Citadel Advisors LLC | 13,965 | 0.31% | $19.27K | New | 0.00% |
| StoneX Group Inc. | 11,814 | 0.26% | $21.88K | New | 0.00% |
| Geode Capital Management, LLC | 11,794 | 0.26% | $16.27K | −20,355 | 0.00% |
| Morgan Stanley | 10,733 | 0.24% | $14.81K | New | 0.00% |
| Virtu Financial LLC | 10,690 | 0.24% | $15 | New | 0.00% |
| Tower Research Capital LLC (TRC) | 4,984 | 0.11% | $6.88K | +3,881 | 0.00% |
| SBI Securities Co., Ltd. | 2,676 | 0.06% | $3.69K | +2,593 | 0.00% |
| Jones Financial Companies Lllp | 1,000 | 0.02% | $1.42K | – | 0.00% |
| Integrated Wealth Concepts LLC | 702 | 0.02% | $969 | New | 0.00% |
| UBS Group AG | 201 | 0.00% | $277 | −3,411 | 0.00% |
| BlackRock, Inc. | 51 | 0.00% | $70 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 24 | 1M | 11.8% | 14 / 3 | 2 / 1 | 0M | 0M |
| Q1 2026 | 11 | 0M | 1.2% | 2 / 2 | 1 / 2 | 0M | 0M |
| Q4 2025 | 11 | 0M | 0.5% | 11 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ENVB | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 35,417 | 0.79% | $48.88K | 0.11% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 14,912 | 0.33% | $20.58K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 11,555 | 0.26% | $26.58K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 911 | 0.02% | $2.10K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph Edward Tucker | Chief Executive Officer, Director | 962,562 | 21.51% | Jun 3, 2026 |
| Kevin Michael Coveney | Chief Financial Officer | 180,746 | 4.04% | Jun 3, 2026 |
| Peter J. Facchini | Chief Innovation Officer | 559,357 | 12.50% | Jun 3, 2026 |
| Michael D. Webb | Director | 26,416 | 0.59% | Jun 3, 2026 |
| Frank Pasqualone | Director | 26,423 | 0.59% | Jun 3, 2026 |
| Sheila DeWitt | Director | 26,306 | 0.59% | Jun 3, 2026 |
| Marcus Schabacker | Director | 26,418 | 0.59% | Jun 3, 2026 |
| George A. Kegler | Director | 26,418 | 0.59% | Jun 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| George A. Kegler Director | Jun 1, 2026 | Award | +18,518 | – | – | 26,418 |
| Peter J. Facchini Chief Innovation Officer | Jun 1, 2026 | Award | +25,000 | – | – | 27,755 |
| Kevin Michael Coveney Chief Financial Officer | Jun 1, 2026 | Award | +133,333 | – | – | 180,746 |
| Michael D. Webb Director | Jun 1, 2026 | Award | +18,518 | – | – | 26,416 |
| Joseph Edward Tucker Chief Executive Officer, Director | Jun 1, 2026 | Award | +201,124 | – | – | 271,479 |
| Sheila DeWitt Director | Jun 1, 2026 | Award | +18,518 | – | – | 26,306 |
| Marcus Schabacker Director | Jun 1, 2026 | Award | +18,518 | – | – | 26,418 |
| Frank Pasqualone Director | Jun 1, 2026 | Award | +18,518 | – | – | 26,423 |
| Joseph Edward Tucker Chief Executive Officer, Director | Dec 23, 2025 | Award | +60,296 | – | – | 70,355 |
| Kevin Michael Coveney Chief Financial Officer | Dec 23, 2025 | Award | +40,198 | – | – | 47,413 |
| Michael D. Webb Director | Dec 23, 2025 | Award | +7,633 | – | – | 7,898 |
| Frank Pasqualone Director | Dec 23, 2025 | Award | +7,633 | – | – | 7,904 |
| George A. Kegler Director | Dec 23, 2025 | Award | +7,633 | – | – | 7,900 |
| Sheila DeWitt Director | Dec 23, 2025 | Award | +7,633 | – | – | 7,788 |
| Marcus Schabacker Director | Dec 23, 2025 | Award | +7,633 | – | – | 7,900 |
| Joseph Edward Tucker CHIEF EXECUTIVE OFFICER, Director | May 8, 2025 | Award | +98,866 | – | – | 120,711 |
| Peter J. Facchini CHIEF INNOVATION OFFICER | May 8, 2025 | Award | +24,717 | – | – | 33,058 |
| Kevin Michael Coveney CHIEF FINANCIAL OFFICER | May 8, 2025 | Award | +74,150 | – | – | 86,584 |
| Michael D. Webb Director | Oct 9, 2024 | Award | +47,733 | – | – | 47,733 |
| Kevin Michael Coveney CHIEF FINANCIAL OFFICER | Oct 9, 2024 | Award | +100,000 | – | – | 186,500 |
| Marcus Schabacker Director | Oct 9, 2024 | Award | +47,733 | – | – | 48,053 |
| George A. Kegler Director | Oct 9, 2024 | Award | +47,733 | – | – | 48,053 |
| Joseph Edward Tucker CHIEF EXECUTIVE OFFICER, Director | Oct 9, 2024 | Award | +161,633 | – | – | 335,829 |
| Peter J. Facchini CHIEF INNOVATION OFFICER | Oct 9, 2024 | Award | +40,000 | – | – | 130,856 |
| Frank Pasqualone Director | Oct 9, 2024 | Award | +47,733 | – | – | 48,733 |
| Sheila DeWitt Director | Oct 9, 2024 | Award | +27,845 | – | – | 27,845 |
| Peter J. Facchini CHIEF INNOVATION OFFICER | Feb 22, 2024 | Award | +50,000 | – | – | 90,856 |
| Kevin Michael Coveney CHIEF FINANCIAL OFFICER | Feb 22, 2024 | Award | +60,000 | – | – | 86,500 |
| Joseph Edward Tucker CHIEF EXECUTIVE OFFICER, Director | Feb 22, 2024 | Award | +100,000 | – | – | 174,196 |
| Frank Pasqualone Director | Sep 15, 2023 | Buy | +1,000 | $2.14 | $2.14K | 1,000 |
| Kevin Michael Coveney Chief Financial Officer | Mar 13, 2023 | Award | +26,500 | – | – | 26,500 |
| Peter J. Facchini Chief Innovation Officer | Jan 25, 2023 | Award | +17,000 | – | – | 40,865 |
| Joseph Edward Tucker Chief Executive Officer, Director | Jan 25, 2023 | Award | +44,000 | – | – | 74,196 |
| Jillian Marie Hagel Vice President of Innovation | Jan 25, 2023 | Award | +12,000 | – | – | 35,802 |
| Avani Kanubaddi President and COO | Jan 25, 2023 | Award | +10,000 | – | – | 48,346 |
| Joseph Edward Tucker Chief Executive Officer, Director | Oct 13, 2021 | Award | +1,374 | – | – | 15,196 |
| Joseph Edward Tucker Chief Executive Officer, Director | Oct 13, 2021 | Award | +15,000 | – | – | 30,196 |
| Peter J. Facchini Chief Scientific Officer | Oct 13, 2021 | Award | +1,021 | – | – | 13,356 |
| Peter J. Facchini Chief Scientific Officer | Oct 13, 2021 | Award | +10,500 | – | – | 23,856 |
| Jillian Marie Hagel Chief Technology Officer | Oct 13, 2021 | Award | +10,500 | – | – | 23,802 |
| Jillian Marie Hagel Chief Technology Officer | Oct 13, 2021 | Award | +1,021 | – | – | 13,302 |
| Jillian Marie Hagel Chief Technology Officer | Sep 16, 2021 | Award | +531,602 | – | – | 531,602 |
| Jillian Marie Hagel Chief Technology Officer | Sep 16, 2021 | Award | +82,398 | – | – | 82,398 |
| Peter J. Facchini Chief Scientific Officer | Sep 16, 2021 | Award | +531,602 | – | – | 531,602 |
| Peter J. Facchini Chief Scientific Officer | Sep 16, 2021 | Award | +85,056 | – | – | 85,056 |
| Joseph Edward Tucker Chief Executive Officer, Director | Sep 16, 2021 | Award | +691,083 | – | – | 691,083 |
| Joseph Edward Tucker Chief Executive Officer, Director | Sep 16, 2021 | Award | +691,083 | – | – | 691,083 |
| Douglas Lind Director | Mar 18, 2021 | Award | +2,265 | – | – | 2,265 |
| Buiten John Van Chief Financial Officer | Mar 4, 2021 | Award | +25,000 | – | – | 25,000 |
| Marcus Schabacker Director | Feb 15, 2021 | Award | +15,957 | – | – | 15,957 |
| Solomon Mayer Director | Feb 15, 2021 | Award | +15,957 | – | – | 15,957 |
| George A. Kegler Director | Feb 15, 2021 | Award | +15,957 | – | – | 15,957 |
| Brent Kelton Chief Executive Officer | Feb 5, 2019 | Other | +986,777 | – | – | 1,079,953 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −6,657 | $0.30 | $2.00K | 2,310,700 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −1,850 | $0.29 | $537 | 2,310,700 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −58,850 | $0.29 | $17.07K | 2,250,000 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −58 | $0.30 | $17 | 2,349,942 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −15,251 | $0.30 | $4.58K | 2,317,557 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −200 | $0.30 | $60 | 2,317,357 |
| Family 2008 Revocable Trust Dated 02/28/2008 Sikaria 10% owner | Nov 16, 2018 | Sale | −1,500 | $0.30 | $450 | 2,348,442 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.